Lucas is a Scientific Advisor to Engage Bio. He is the co-founder and CSO at Mammoth Biosciences, where he develops gene editing therapies for a range of disease targets. He is also co-founder and GP at SciFounders, a venture capital firm. Lucas completed his PhD in the Jennifer Doudna lab at UC Berkeley.

Melissa is a Scientific Advisor to Engage Bio. She is the co-founder of 4DMolecular Therapeutics, where she advanced multiple genetic medicines into clinical development. She also co-founded IGNITE Immunotherapy which developed oncolytic viral therapies for cancer (acquired by Pfizer). Melissa received a PhD in Chemical and Biomolecular Engineering from UC Berkeley.

Dmitri is a Scientific Advisor to Engage Bio. He is the CSO of Crossbow Therapeutics, where he is developing TCR-mimetic antibodies. He was previously CSO at Jounce Therapeutics, and Global Head of Immuno-Oncology at Sanofi. Dmitri received a PhD in cancer biology from Harvard University.

Taufeeq is the Head of In Vivo Operations at Engage Bio. He was previously the Director of Vivarium / In Vivo operations at TrueBinding and the Facility Manager at the Molecular Medicine Research Institute. Taufeeq obtained his DVM at the College of Veterinary Science & Animal Husbandry, Hyderabad, India.

Ben is the Head of Molecular Biology at Engage Bio. He obtained his PhD at MRC Toxicology Unit in Cambridge, where he focused on understanding the role of RNA in DNA repair mechanisms. Ben later moved to Weill Cornell where he completed a postdoc studying RNA modifications.

Kathryn is the co-founder and Chief Scientific Officer at Engage Bio. Kathryn obtained her PhD in Chemical and Biomolecular Engineering at UC Berkeley. Kathryn then spent 2 years working in therapeutic antibody development at Bayer before joining Harpoon Therapeutics as one of their earliest hires. At Harpoon, Kathryn helped advance four bispecific T cell engagers into the clinic.

Will is the co-founder and CEO of Engage Bio. He was previously VP of mRNA Therapeutic Development at Stanford spinout Rejuvenation Technologies, and prior to that co-founded the diagnostic startup Luminist Labs in 2015 (acquired in 2019, now owned by Viome).